Integratori, messi alla prova delle evidenze
Inositol
Solidità delle prove: Debole
Aggiornato 2026-08-07
Questa guida non è ancora tradotta nella tua lingua, quindi è mostrata in inglese.
Risposta breve
Does inositol improve insulin resistance?
In women with polycystic ovary syndrome, an umbrella review of meta-analyses found inositol improved fasting insulin with moderate certainty, and increased ovulation rates in those who were subfertile. That is a real finding in a defined group. There is no comparable evidence base for inositol as a general glucose supplement.
Prima di assumerlo
Parlane con chi ti prescrive i farmaci prima di aggiungerlo a una terapia, soprattutto se ipoglicemizzante. Non sospendere un farmaco prescritto per prendere un integratore.
Interazioni
Additive with glucose-lowering medication, and often taken alongside metformin in the polycystic ovary syndrome literature specifically because both act on insulin sensitivity.1
Cautela
Chi non dovrebbe assumerlo
Inositol raises ovulation rates in women with polycystic ovary syndrome. If you are taking it for metabolic reasons and not trying to conceive, that is a side effect worth knowing about rather than discovering.1
Cautela
Discuss with your clinician before taking it in pregnancy. Trials exist in that setting, but dose and indication are decisions for someone who knows your history.
Cautela
Il nostro giudizio
Reasonable to discuss with a clinician if you have polycystic ovary syndrome. Outside that, you would be extrapolating from a population you are not in.
Che cosa possiamo dire e vendere dove sei
Le indicazioni salutistiche per questi prodotti non sono autorizzate nella tua regione, quindi questa pagina non contiene alcun link commerciale. È solo informazione.
Nella tua regione non viene mostrato alcun link commerciale.
Come leggere le etichette dell’evidenza
Ogni affermazione di questa pagina porta un’etichetta che indica quanto peso può reggere. Descrive la solidità del risultato, non il prestigio della rivista.
- Evidenza solidaUn grande studio randomizzato, una coorte seguita a lungo, o la concordanza di più studi.
- Evidenza preliminareReale, ma sottile — piccolo, breve, osservazionale o non ancora replicato.
- ControversoRicercatori competenti sono apertamente in disaccordo. Non scegliamo noi da che parte stare.
What the evidence covers
An umbrella review — a review of meta-analyses rather than of trials — assessed 28 pooled analyses of nutritional interventions in polycystic ovary syndrome and graded how much certainty each finding carried. Inositol came out with moderate certainty for improving fasting insulin, alongside a small number of other supplements.
The same review recorded moderate-certainty evidence that inositol increases ovulation rates in subfertile women with the condition. That is the most clinically concrete finding on this whole page, and it has nothing to do with glucose sensors.
Che cosa dicono le prove
In women with polycystic ovary syndrome, inositol supplementation improved fasting insulin with moderate certainty in an umbrella review of meta-analyses.1
Evidenza preliminare
The same review found moderate-certainty evidence that inositol increases ovulation rates in subfertile women with polycystic ovary syndrome.1
Evidenza preliminare
That review found no high-certainty evidence that dietary interventions alone improved health or reproductive outcomes in polycystic ovary syndrome.1
Evidenza preliminare
Why the population matters more than usual here
Polycystic ovary syndrome is strongly associated with insulin resistance, which is why an insulin-sensitising supplement was tested there in the first place. But a finding in a group selected for a specific endocrine disorder does not transfer to a general reader whose only concern is a borderline HbA1c.
Every other supplement on this page is at least tested in populations resembling our readers. This one is not, and the honest framing is that it is well studied in a place most people reading this do not stand.
Domande frequenti
- Should I take inositol for prediabetes?
- The evidence base is in polycystic ovary syndrome, not prediabetes. Applying it to yourself means assuming a finding transfers between quite different populations, which is exactly the reasoning this site tries to avoid.
- What is the difference between myo-inositol and D-chiro-inositol?
- They are different isomers, often sold together in a fixed ratio on the basis that this reflects physiological proportions. Trial evidence is mostly on myo-inositol, and the case for particular ratios is commercial more than it is established.
Bibliografia
- 1.Moslehi N, Zeraattalab-Motlagh S, Rahimi Sakak F, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P (2023). Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Nutrition Reviews. 10.1093/nutrit/nuac075